Projects

National

• Characterization of the soluble form of carbonic anhydrase IX in molecular subtypes of breast cancer and its significance for prognosis.
  Program: VEGA
  Duration: 1. 1. 2024 – 31. 12. 2027

• Regulation of hypoxic signalling in renal carcinoma with focus on the role of carbonic anhydrase IX in the tumor microenvironment
  Program: VEGA
  Duration: 1. 1. 2024 – 31. 12. 2027

• Surface modification of 3D printed titanium spinal implants to improve functional properties
  Program: VEGA
  Duration: 1. 1. 2024 – 31. 12. 2026

• Cell-in-cell phenomena as microevolutionary processes in cancer progression: a role for hypoxia-induced carbonic anhydrase IX
  Program: SRDA
  Duration: 1. 7. 2020 – 30. 6. 2024

• Carbonic anhydrase IX: one of the key components of exosomes secreted from cancer cells
  Program: VEGA
  Duration: 1. 1. 2020 – 31. 12. 2023

• Clinical evaluation of prognostic and predictive value of tissue and serum Carbonic Anhydrase IX in breast cancer
  Program: Other projects
  Duration: 1. 11. 2019 – 31. 12. 2022

• Regulation of pyruvate dehydrogenase kinase 1 activity in the control of glycolytic metabolism in hypoxic tumors
  Program: VEGA
  Duration: 1. 1. 2019 – 31. 12. 2022

• Activity Assay of Transfer Factor, Immunostimulatory Drug from Leukocytes Extract And Its Preparation Standardization
  Program: SRDA
  Duration: 1. 7. 2016 – 31. 12. 2020

• Drug repurposing as a novel approach to therapy of colorectal carcinoma: molecular mechanisms and potential applications
  Program: VEGA
  Duration: 1. 1. 2016 – 31. 12. 2019

• Soluble and/or exosome-associated Carbonic anhydrase IX as a biologically active molecule.
  Program: VEGA
  Duration: 1. 1. 2016 – 31. 12. 2019

• Extracelular form of hypoxia - induced tumor - associated carbonic adhydrase IX /CA IX/: molecular mechanisms of shedding and biological significance in oncogenesis
  Program: VEGA
  Duration: 1. 1. 2006 – 31. 12. 2008

• -
  Program: VEGA
  Duration: 1. 1. 2005 – 1. 12. 2007